To date, however, similar studies have not been performed in recipients of corneal or other tissue transplants. Recognising this important gap in the field, VISICORT will progress the state of the art in CT as well as in the broader area of the adverse immune response to tissue transplants and bioartificial implants.

The project focuses on 2-year outcomes from multi-site prospective biological sampling and clinical follow-up of Full-Thickness and Posterior Lamellar-CT recipients focuses on comparing the clinical outcome of Low- and High-Risk CT patients.